Elixir Energy has secured $5 million through a discounted placement to support ongoing flow tests at Lorelle-3H, artificial lift trials at Diona-1, and initiate a strategic review of its Taroom Trough assets.
- Placement raises $5 million at $0.04 per share
- Funds allocated to Lorelle-3H soak and flow testing
- Diona-1 artificial lift and testing pending JV approval
- Strategic review to explore farm-outs, partnerships, or self-funding
- Placement shares issued to institutional and sophisticated investors
Capital Raise Targets Key Operational and Strategic Milestones
Elixir Energy Limited (ASX:EXR) has completed a $5 million placement priced at $0.04 per share, representing a 20% discount to the last closing price. The funds will bankroll critical phases of its Queensland Taroom Trough gas projects, including the ongoing 60-day soak and second phase flow testing at the Lorelle-3H well, as well as artificial lift and flow testing at Diona-1, subject to joint venture approval.
Supporting Data Gathering and Resource Certification
The placement proceeds will also cover downhole pressure monitoring and technical evaluations at Lorelle-3H, alongside engagement of independent reserve certifiers to validate post-flow performance. Meanwhile, Diona-1’s artificial lift testing aims to unlock further production insights, feeding into the potential certification of Elixir’s contingent gas resources estimated at approximately 3.5 trillion cubic feet (2C) within the Taroom Trough basin.
Strategic Review to Define Corporate Path Forward
With the initial exploration and appraisal phases yielding confirmation of Shell’s primary plays extending into Elixir’s permits, and encouraging flow test results at Lorelle-3H supporting commercial development models, the company is initiating a strategic review. This process will evaluate a spectrum of options including self-funding continued appraisal, farm-outs to strategic or financial partners, joint ventures, or other corporate transactions designed to maximise shareholder value.
The review explicitly preserves flexibility, with no predetermined outcomes or timelines. Its objectives include accelerating appraisal and potential commercialisation of the Taroom Trough assets, accessing capital or technical partnerships otherwise unavailable, and maximising risk-adjusted returns.
Placement Details and Market Reception
The placement involves issuing 125 million new shares under the company’s Listing Rule 7.1 capacity, with settlement expected on 19 August 2026 and allotment on 20 August. Institutional and sophisticated investors supported the raise, with Euroz Hartleys acting as lead manager and Sternship Adviser, alongside co-managers Chieftain Securities and Canaccord Genuity. Broker fees of 6% plus GST will be paid in cash.
Elixir is the largest acreage holder in the Taroom Trough, a multi-TCF basin-centred gas play strategically positioned near major pipelines and LNG export infrastructure. The company’s resource base and proximity to Shell’s operations underpin its appraisal efforts and the rationale for the strategic review.
Bottom Line?
Elixir’s $5 million placement funds key testing milestones and launches a strategic review that could reshape its Taroom Trough ambitions, but outcomes remain uncertain.
Questions in the middle?
- How will JV approval timing impact Diona-1 artificial lift testing?
- What strategic partnerships or farm-out structures might emerge from the review?
- How will flow testing results influence the valuation and attractiveness of Elixir’s assets?